The DES Center

Filter Your Results

 

News

 

FDA Grants Breakthrough Device Designation for Concept Medical's MagicTouch Sirolimus-Coated Balloon

May 2, 2019 -- Concept Medical Inc. has been granted Breakthrough Device Designation from the FDA for the company's MagicTouch sirolimus drug-coated balloon (DCB) catheter…

CENTURY II Compares Bioresorbable and Permanent Polymer Drug-Eluting Stents in Multivessel CAD at 5 Years

April 30, 2019 -- The 5‐year results of the CENTURY II randomized clinical trial were published by Andrés Iñiguez, MD, et al online in Catheterization and Card…

Orchestra BioMed's Virtue Sirolimus-Eluting Balloon Receives FDA Breakthrough Device Designation

April 24, 2019 -- Orchestra BioMed, Inc. announced that it has secured FDA Breakthrough Device designation for its noncoated Virtue sirolimus-eluting balloon (SEB) for the tre…

Seven-Year Outcomes of RESET Trial Compare Sirolimus and Everolimus DESs

April 15, 2019 -- Hiroki Shiomi, MD, et al published 7-year outcomes from the RESET trial of drug-eluting stents (DESs) in Journal of the American College of Cardiology (JACC…

One-Year Findings Published From the SORT OUT VIII Trial

April 2, 2019 -- One-year follow-up findings from the SORT OUT VIII trial were published by Michael Maeng, MD, et al in Journal of the American College of Cardiology (JACC): C…

SMART-CHOICE Data Show That Stopping Aspirin 3 Months After Stenting Does Not Increase Mortality Risk

March 26, 2019 -- The American College of Cardiology (ACC) announced the presentation of data from the SMART-CHOICE trial that suggest patients who stopped taking aspirin 3 mo…

STOPDAPT-2 Data Show Improved Outcomes for Stent Patients on a P2Y12 Inhibitor Who Stop Taking Aspirin After 1 Month

March 18, 2019 -- Data from the STOPDAPT-2 trial show that patients who stopped taking aspirin 1 month after undergoing coronary stenting but continued taking a P2Y12 inhibito…

Biotronik Launches Orsiro DES With Presentations of Data at CRT

March 6, 2019 -- Biotronik announced that 3-year outcomes from the BIO-RESORT randomized controlled trial were presented by Clemens von Birgelen, MD, as late-breaking clinical…

 

advertisement

 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Cardiac Interventions Today

Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007 and each edition contains a variety of topics in a flexible format, including articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's interventional cardiology practices.